Market News & Trends
Abbott & UCSF Discover New Virus is Linked to Hepatitis C
Abbott and University of California San Francisco (UCSF) published research identifying a newly discovered human virus, known as human pegivirus 2 (HPgV-2), and proving it…
MedPharm Announces Formation of US Subsidiary & First Appointment
MedPharm recently announced the formation of its new US-based laboratories, MP Pharma Services Inc. With a targeted operational date in Q1 2016, the services offered…
MGB Biopharma Successfully Completes Phase I Clinical Trial
MGB Biopharma recently announced it has successfully completed a Phase I clinical trial of an oral formulation of its lead product, MGB-BP-3, which is being…
Protea Announces Biopharm Industry Collaboration With Agilent
Protea Biosciences Group, Inc. recently announced it is collaborating with Agilent Technologies, Inc. to address customer challenges within existing Biopharma bioanalytical workflows in order to…
Exostar Launches Cybersecurity Risk Assessment Solution
Exostar, whose cloud-based solutions help companies in aerospace and defense, life sciences, and healthcare mitigate risk and solve their identity and access challenges, recently announced…
Pharmaceutical Deals Crucial to Offsetting $2.5-Billion Cost of Developing a Novel Drug
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster status, deal-making is becoming increasingly…
Celldex Therapeutics Initiates Phase I/II Study
Celldex Therapeutics, Inc. recently announced the initiation of an open-label, Phase I/II safety and tolerability study examining the investigational combination of varlilumab and Roche's atezolizumab…
Soligenix Announces Initiation of Pivotal Phase III Clinical Trial
Soligenix, Inc. recently announced that patient enrollment has been opened for its Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating SGX301 (synthetic hypericin), as a…
Pharma Outsourcing M&As Set for Record Year in 2015
A drastic increase in Mergers and Acquisitions (M&A) activity propelled the value of pharmaceutical outsourcing deals from $9.9 billion in 2014 to nearly $17.6 billion…
Ajinomoto Althea Launches Process & Analytical Development Services for ADC Therapeutics
Ajinomoto Althea, Inc., a leading provider of biopharmaceutical contract development and manufacturing services, recently announced it is expanding its existing biological drug product manufacturing operations…
Global Immunology Treatment Market Will Exceed $74 Billion by 2022
Despite the imminent patent expiry of many therapies, the global immunology treatment market is set to expand, from $61.5 billion in 2015 to reach $74.2…
Ashland Aids Pharmaceutical Manufacturers With Formulation Services
Pharmaceutical scientists at Ashland understand how polymers interact with complex drug molecules. These experts presented at CPhI India to explain how Ashland is providing formulation…
Vetter Receives Internationally Recognized AEO-F Certificate
Vetter has received the status of Authorized Economic Operator Full (AEO-F) from the European Union confirming Vetter reliability, solvency, and high safety standards in international…
ProQR Announces R&D Day; Provides Update on Innovation Portfolio
ProQR Therapeutics N.V. recently announced an update on the innovation pipeline and an R&D day for investors. ProQR has been investing in its Innovation Platform…
Caladrius Biosciences Announces Two-Year Study Results
Caladrius Biosciences, Inc. recently announced the publication of 2-year results from a Phase I clinical study of an autologous Regulatory T cell (Treg) immunotherapy for…
BioCellChallenge Obtains Unprecedented In Vivo Results
BioCellChallenge SAS recently announced its positive results from in-vivo tests of a therapeutic antibody. The results confirm the efficacy of BioCellChallenge’s ImmunoCellin technology, which allows…
Adaptimmune & Universal Cells Announce Collaboration & License Agreement
Adaptimmune Therapeutics plc and Universal Cells Inc. recently announced they have entered into a collaboration and exclusive license agreement for the development of allogeneic T-cell…
Pfizer Awards Flagship OTC Product Manufacturing Contract to Catalent
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, recently announced…
Aptar Pharma Presents a Step Change in the Performance of DF30Plus for PMDIs Incorporating COC
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection, and spray delivery systems for biotech, healthcare, and pharma products, will present its…
SteadyMed Demonstrates Potential for Reduced Infusion Site Sensitivity Associated With Trevyent Compared to Remodulin
SteadyMed Ltd., a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet parenteral delivery needs, recently…
